PharmaBlock Sciences Nanjing Inc Class A Financial Flexibility Index
PharmaBlock Sciences Nanjing Inc Class A financial flexibility index. PharmaBlock Sciences Nanjing Inc Class A (300725) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of CN¥87.61 Million (operating CF CN¥83.36 Million minus capex CN¥4.24 Million) represents 0% of total liabilities (CN¥645.64 Million). See PharmaBlock Sciences Nanjing Inc Class A (300725) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PharmaBlock Sciences Nanjing Inc Class A (2013–2025)
Financial flexibility index of PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2025. Historical Financial Flexibility Index trend for PharmaBlock Sciences Nanjing Inc Class A across 13 annual periods. Check how high is PharmaBlock Sciences Nanjing Inc Class A's earnings quality to evaluate the quality of earnings relative to operating cash generation.
PharmaBlock Sciences Nanjing Inc Class A Financial Flexibility Index by Year (2013–2025)
PharmaBlock Sciences Nanjing Inc Class A financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for PharmaBlock Sciences Nanjing Inc Class A. For the full cash flow conversion analysis, see PharmaBlock Sciences Nanjing Inc Class A (300725) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥807.49 Million | CN¥667.36 Million | CN¥1.04 Billion | ▲ +259.3% |
| 2024 | 0.22x | CN¥420.95 Million | CN¥302.82 Million | CN¥1.95 Billion | ▼ -12.7% |
| 2023 | 0.25x | CN¥562.61 Million | CN¥246.84 Million | CN¥2.27 Billion | ▼ -32.1% |
| 2022 | 0.36x | CN¥804.52 Million | CN¥246.61 Million | CN¥2.20 Billion | ▼ -56.9% |
| 2021 | 0.85x | CN¥743.79 Million | CN¥238.03 Million | CN¥879.21 Million | ▲ +29.5% |
| 2020 | 0.65x | CN¥346.69 Million | CN¥271.51 Million | CN¥530.57 Million | ▼ -37.3% |
| 2019 | 1.04x | CN¥300.57 Million | CN¥127.04 Million | CN¥288.27 Million | ▼ -19.3% |
| 2018 | 1.29x | CN¥208.60 Million | CN¥160.16 Million | CN¥161.43 Million | ▼ -20.5% |
| 2017 | 1.63x | CN¥103.70 Million | CN¥54.64 Million | CN¥63.80 Million | ▲ +19.9% |
| 2016 | 1.36x | CN¥61.02 Million | CN¥22.76 Million | CN¥45.00 Million | ▼ -5.6% |
| 2015 | 1.44x | CN¥37.23 Million | CN¥27.52 Million | CN¥25.92 Million | ▼ -3.5% |
| 2014 | 1.49x | CN¥21.39 Million | CN¥11.91 Million | CN¥14.38 Million | ▼ -9.3% |
| 2013 | 1.64x | CN¥24.55 Million | CN¥18.32 Million | CN¥14.97 Million | — |